TRPC5 and breast cancer: The up-regulation of TrpC5 in BC-derived L-EVs is responsible for adriamycin trapping, while the intercellular transfer of TrpC5 to recipient cells stimulates the production of the MDR1 protein, thus conferring chemoresistance to drug-sensitive cells [59].